ROYALTY PHARMA PLC's ticker is RPRX and the CUSIP is G7709Q104. A total of 317 filers reported holding ROYALTY PHARMA PLC in Q2 2023. The put-call ratio across all filers is 0.31 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $4,464,585 | -17.8% | 123,913 | -9.9% | 3.31% | -22.0% |
| Q4 2022 | $5,432,498 | -3.4% | 137,462 | -1.7% | 4.24% | +17.4% |
| Q3 2022 | $5,621,000 | -19.5% | 139,890 | -15.7% | 3.61% | -2.9% |
| Q2 2022 | $6,980,000 | +75.6% | 166,040 | +62.7% | 3.72% | +120.0% |
| Q1 2022 | $3,976,000 | -24.8% | 102,052 | -23.0% | 1.69% | +24.5% |
| Q4 2021 | $5,285,000 | -6.2% | 132,613 | -14.9% | 1.36% | +19.6% |
| Q3 2021 | $5,632,000 | -63.8% | 155,848 | -59.0% | 1.14% | -53.9% |
| Q2 2021 | $15,579,000 | -21.2% | 380,061 | -16.1% | 2.46% | -15.8% |
| Q1 2021 | $19,758,000 | +100.6% | 452,948 | +130.2% | 2.93% | +117.6% |
| Q4 2020 | $9,849,000 | – | 196,790 | – | 1.34% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Memorial Sloan Kettering Cancer Center | 2,680,644 | $106,824,000 | 67.12% |
| SIGULER GUFF ADVISERS, LLC | 6,761,970 | $269,465,000 | 56.37% |
| Vantage Consulting Group Inc | 4,601,152 | $183,355,000 | 49.30% |
| Indie Asset Partners, LLC | 805,982 | $32,118,000 | 23.31% |
| HARVARD MANAGEMENT CO INC | 3,464,990 | $138,080,000 | 12.96% |
| Brown University | 621,759 | $24,777,000 | 6.04% |
| Overbrook Management Corp | 729,125 | $29,056,000 | 5.86% |
| Bleichroeder LP | 824,033 | $32,838,000 | 5.13% |
| Geo Capital Gestora de Recursos Ltd | 200,692 | $7,998,000 | 3.81% |
| Lagoda Investment Management, L.P. | 140,435 | $5,596,000 | 2.65% |